- UK | MHRA and NICE Continue Real-World Evidence Scientific Dialogue Programme — Expanding Early RWE Discussion to Medical Devices Gallery
UK | MHRA and NICE Continue Real-World Evidence Scientific Dialogue Programme — Expanding Early RWE Discussion to Medical Devices
2026, June 2026, Members-Only, Moderate Update, RWD to Support Reg Decisions, Secondary Use of Existing Data, UK
UK | MHRA and NICE Continue Real-World Evidence Scientific Dialogue Programme — Expanding Early RWE Discussion to Medical Devices
Please login to view this page.
UK | HRA Publishes Two-Year Plan to Support Safe AI-Powered Innovation in Health and Social Care Research
Please login to view this page.
UK | NICE Reports Major Shift Away From SABA-Only Asthma Treatment — More Than One Million People Now Using AIR or MART Combination Inhalers
Please login to view this page.
- UK | MHRA Consults on Draft Rare Disease Therapies Regulatory Framework — Proposed Investigational Marketing Authorisation Would Embed RWE Into Lifecycle Access Model Gallery
UK | MHRA Consults on Draft Rare Disease Therapies Regulatory Framework — Proposed Investigational Marketing Authorisation Would Embed RWE Into Lifecycle Access Model
UK | MHRA Consults on Draft Rare Disease Therapies Regulatory Framework — Proposed Investigational Marketing Authorisation Would Embed RWE Into Lifecycle Access Model
Please login to view this page.
UK | MHRA Draft 2026 Medical Device Regulations — International Reliance, UDI and Lifecycle Traceability Move Into Draft Legislative Form
Please login to view this page.
UK | HRA Overhauls Non-CTIMP Requirements — Implementation from 28 April 2026
Please login to view this page.
UK | ABPI Calls for Data-Enabled Clinical Trials Model to Restore Global Competitiveness
Please login to view this page.
UK | Global Impact of CPRD Highlights Value of UK Health Data for Research and Regulation
Please login to view this page.
UK | Regulators Issue Joint Statement on Enabling Innovation in Space Health and Medicine
Please login to view this page.










